DiscoverHarvard Data Science Review PodcastHow Do Data Help Us Weigh the Benefit, Risk, and Cost of Ozempic (and other “Magic” Drugs)?
How Do Data Help Us Weigh the Benefit, Risk, and Cost of Ozempic (and other “Magic” Drugs)?

How Do Data Help Us Weigh the Benefit, Risk, and Cost of Ozempic (and other “Magic” Drugs)?

Update: 2023-05-31
Share

Description

Why are we seeing an unprecedented rise in prescription drug use in the U.S.? Is Ozempic really the magic cure for weight loss? How has the landscape of prescription medicine changed over time, and why are currently facing supply issues? On today’s episode, we explore hotly debated drugs and what the data says about prescribing them.


Our Guests:


  • Dr. Heather Levites, fellowship-trained plastic surgeon with a special interest in advanced cosmetic surgery. She earned her undergraduate degree at MIT and her MD from the State University of New York at Stony Brook, and completed her plastic surgery training at Duke University. She currently practices in Chapel Hill, North Carolina. 

  • Dr. John Schneider, Associate Professor of Otolaryngology and Division Chief of Rhinology at the Washington University School of Medicine in St. Louis. 


 

Comments 
In Channel
What is Data Science?

What is Data Science?

2023-08-3040:19

loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

How Do Data Help Us Weigh the Benefit, Risk, and Cost of Ozempic (and other “Magic” Drugs)?

How Do Data Help Us Weigh the Benefit, Risk, and Cost of Ozempic (and other “Magic” Drugs)?

Harvard Data Science Review